(Q57703684)

English

The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)

article

In more languages

Statements

scholarly article

0 references

The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) (English)

0 references

1 reference

based on heuristic

inferred from title

Giuseppe Remuzzi

10

object named as

G Remuzzi

0 references

author name string

B M Brenner

1

0 references

M E Cooper

2

0 references

D de Zeeuw

3

0 references

J P Grunfeld

4

0 references

W F Keane

5

0 references

K Kurokawa

6

0 references

J B McGill

7

0 references

W E Mitch

8

0 references

H H Parving

9

0 references

A B Ribeiro

11

0 references

M D Schluchter

12

0 references

D Snavely

13

0 references

Z Zhang

14

0 references

R Simpson

15

0 references

D Ramjit

16

0 references

S Shahinfar

17

0 references

language of work or name

0 references

publication date

December 2000

0 references

Journal of the Renin-Angiotensin-Aldosterone System

0 references

1

0 references

4

0 references

328-35

0 references

Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota.

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

NIDDM is the Major Cause of Diabetic End-Stage Renal Disease: More Evidence From a Tri-Ethnic Community

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

A simple method of estimating progression of chronic renal failure

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Renal protective effect of enalapril in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.062

21 January 2018

Identifiers

10.3317/JRAAS.2000.062

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57703684&oldid=1582905853"